Carmen Ivorra1, Consuelo García-Vicent2, Francisco Ponce3, Graciela Ortega-Evangelio4, José Antonio Fernández-Formoso5, Empar Lurbe6. 1. Cardiovascular Risk Unit, Hospital General, University of Valencia, Department of Pediatrics, Avenida Tres Cruces 2, Valencia, 46014, Spain; CIBER Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, 28049, Spain. Electronic address: carmen.ivorra@uv.es. 2. Cardiovascular Risk Unit, Hospital General, University of Valencia, Department of Pediatrics, Avenida Tres Cruces 2, Valencia, 46014, Spain; CIBERER, Instituto de Salud Carlos III, Madrid, 28049, Spain. Electronic address: jec_jec_@hotmail.com. 3. Cardiovascular Risk Unit, Hospital General, University of Valencia, Department of Pediatrics, Avenida Tres Cruces 2, Valencia, 46014, Spain; CIBER Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, 28049, Spain. Electronic address: siscopz80@hotmail.com. 4. Cardiovascular Risk Unit, Hospital General, University of Valencia, Department of Pediatrics, Avenida Tres Cruces 2, Valencia, 46014, Spain. Electronic address: graore2@gmail.com. 5. CIBER Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, 28049, Spain. Electronic address: joseaff@yahoo.es. 6. Cardiovascular Risk Unit, Hospital General, University of Valencia, Department of Pediatrics, Avenida Tres Cruces 2, Valencia, 46014, Spain; CIBER Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, 28049, Spain. Electronic address: empar.lurbe@uv.es.
Abstract
BACKGROUND: Despite the adverse effects of maternal smoking during pregnancy on the newborn's health are well-known, in the pediatric population, a high prevalence exists that is very much affected by second hand smoke (SHS). This study aims to investigate the impact of maternal smoking habits during pregnancy on cotinine levels in newborns during the first days of life. The high association between cotinine concentration in maternal and umbilical cord blood (UCB) has been previously reported, but the levels of blood cotinine that remain in infants born to smokers is unknown. METHODS: Cotinine concentration was measured in UCB, in maternal and newborn peripheral blood. Data from UCB sample dyads of ninety mothers and from seventy-one newborns were analyzed. RESULTS: Cotinine levels were significantly different among non-smokers (9.9 ± 5.9 ng/ml), moderate (67.3 ± 7.4 ng/ml), and heavy smokers (137.7 ± 19.5 ng/ml) (p<0.0001). Significant correlations were found between maternal and UCB cotinine (r=0.748; p<0.001), and between UCB and newborn plasma cotinine at 48 h after birth (r=0.541; p<0.001). The smokers exposed their infants to cotinine with a median of 31.7 ± 8.6 ng/ml (moderate) or 59.1 ± 13.3 ng/ml (heavy smokers) until at least, 48 h after birth. Reduced birth weight and length were significantly related with UCB cotinine levels. CONCLUSIONS: A positive association between UCB and plasmatic cotinine in newborns was found. The high cotinine levels detected in newborns from smoker mothers indicates that their infants are subjected to elevated SHS from birth. These results can help to reinforce the awareness of the adverse effects of smoking during pregnancy.
BACKGROUND: Despite the adverse effects of maternal smoking during pregnancy on the newborn's health are well-known, in the pediatric population, a high prevalence exists that is very much affected by second hand smoke (SHS). This study aims to investigate the impact of maternal smoking habits during pregnancy on cotinine levels in newborns during the first days of life. The high association between cotinine concentration in maternal and umbilical cord blood (UCB) has been previously reported, but the levels of blood cotinine that remain in infants born to smokers is unknown. METHODS:Cotinine concentration was measured in UCB, in maternal and newborn peripheral blood. Data from UCB sample dyads of ninety mothers and from seventy-one newborns were analyzed. RESULTS:Cotinine levels were significantly different among non-smokers (9.9 ± 5.9 ng/ml), moderate (67.3 ± 7.4 ng/ml), and heavy smokers (137.7 ± 19.5 ng/ml) (p<0.0001). Significant correlations were found between maternal and UCB cotinine (r=0.748; p<0.001), and between UCB and newborn plasma cotinine at 48 h after birth (r=0.541; p<0.001). The smokers exposed their infants to cotinine with a median of 31.7 ± 8.6 ng/ml (moderate) or 59.1 ± 13.3 ng/ml (heavy smokers) until at least, 48 h after birth. Reduced birth weight and length were significantly related with UCB cotinine levels. CONCLUSIONS: A positive association between UCB and plasmatic cotinine in newborns was found. The high cotinine levels detected in newborns from smoker mothers indicates that their infants are subjected to elevated SHS from birth. These results can help to reinforce the awareness of the adverse effects of smoking during pregnancy.
Authors: Dani Smith; Angela Aherrera; Armando Lopez; Enid Neptune; Jonathan P Winickoff; Jonathan D Klein; Gang Chen; Philip Lazarus; Joseph M Collaco; Sharon A McGrath-Morrow Journal: PLoS One Date: 2015-09-15 Impact factor: 3.240
Authors: Parnian Kheirkhah Rahimabad; Thilani M Anthony; A Daniel Jones; Shakiba Eslamimehr; Nandini Mukherjee; Susan Ewart; John W Holloway; Hasan Arshad; Sarah Commodore; Wilfried Karmaus Journal: Int J Environ Res Public Health Date: 2020-12-20 Impact factor: 3.390
Authors: Hamed Janbazacyabar; Jeroen van Bergenhenegouwen; Johan Garssen; Thea Leusink-Muis; Ingrid van Ark; Marthe T van Daal; Gert Folkerts; Saskia Braber Journal: Front Immunol Date: 2021-12-23 Impact factor: 7.561